Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Summary
A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the progression of myopia in children
Official title: A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops in Slowing the Progression of Myopia in Children
Key Details
Gender
All
Age Range
6 Years - 12 Years
Study Type
INTERVENTIONAL
Enrollment
777
Start Date
2022-03-15
Completion Date
2025-08
Last Updated
2025-07-30
Healthy Volunteers
No
Conditions
Interventions
Lower dose atropine sulfate eye drops
administer to eyes
Low dose atropine sulfate eye drops
administer to eyes
placebo
administer to eyes
Locations (1)
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China